UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial

Nutrients, 2022-11, Vol.14 (22), p.4784

2022

Volltextzugriff (PDF)

Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy

The Journal of immunology (1950), 2004-10, Vol.173 (7), p.4699-4707

2004

Volltextzugriff (PDF)

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc RI × anti-HER-2 neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

British journal of cancer, 2003-12, Vol.89 (12), p.2234-2243

2003

Volltextzugriff (PDF)

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma

International journal of cancer, 2005-11, Vol.117 (4), p.596-604

2005

Volltextzugriff (PDF)

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma

Blood, 2003-01, Vol.101 (1), p.253-258

2003

Volltextzugriff (PDF)

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (17), p.5595-5600

2003

Volltextzugriff (PDF)

IL-12: a promising adjuvant for cancer vaccination

Cancer Immunology, Immunotherapy, 2003-03, Vol.52 (3), p.133-144

2003

Volltextzugriff (PDF)

FcγRI (CD64) Contributes Substantially to Severity of Arthritis, Hypersensitivity Responses, and Protection from Bacterial Infection

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.391-402

2002

Volltextzugriff (PDF)

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

Critical reviews in oncology/hematology, 2001-04, Vol.38 (1), p.47-61

2001

Volltextzugriff (PDF)

Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcγRI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (Filgrastim) for treatment of advanced breast cancer

Cancer Immunology, Immunotherapy, 1997-11, Vol.45 (3-4), p.207-209

1997

Volltextzugriff (PDF)

Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients

Journal of interferon & cytokine research, 2004-07, Vol.24 (7), p.411-415

2004

Volltextzugriff (PDF)

CpG oligodeoxynucleotides enhance FcγRI-mediated cross presentation by dendritic cells

International immunology, 2004-08, Vol.16 (8), p.1091-1098

2004

Volltextzugriff (PDF)

Immunotherapeutic perspective for bispecific antibodies

Immunology Today, 2000-08, Vol.21 (8), p.391-397

2000

Volltextzugriff (PDF)

Pegylated interferon-α2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

Anti-cancer drugs, 2004-07, Vol.15 (6), p.587-591

2004

Volltextzugriff (PDF)

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy : The promise of monoclonal antibodies for the therapy of cancer

Critical reviews in oncology/hematology, 2001, Vol.38 (1), p.47-61

2001

Volltextzugriff (PDF)

Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies

The Journal of immunology (1950), 1997-12, Vol.159 (11), p.5629

1997

Volltextzugriff (PDF)

Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantation

British journal of haematology, 1997-03, Vol.96 (3), p.641-643

1997

Volltextzugriff (PDF)

CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells

International immunology, 2004-08, Vol.16 (8), p.1091-1098

2004

Volltextzugriff (PDF)

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.391-402

2002

Volltextzugriff (PDF)

CpG oligodeoxynucleotides enhance Fc RI-mediated cross presentation by dendritic cells

International immunology, 2004-08, Vol.16 (8), p.1091-1098

Bevaart, L.

2004

Volltextzugriff (PDF)

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

Anti-cancer drugs, 2004-07, Vol.15 (6), p.587

2004

Volltextzugriff (PDF)

Fc[gamma]RI (CD64) Contributes Substantially to Severity of Arthritis, Hypersensitivity Responses, and Protection from Bacterial Infection

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.391

2002

Volltextzugriff (PDF)

Radio Continuum Imaging of High-redshift Radio Galaxies

The Astrophysical journal. Supplement series, 1997-03, Vol.109 (1), p.1-44

1997

Volltextzugriff (PDF)

Spatially resolved Lyα absorption in the z = 2.9 radio galaxy 0943–242

Monthly notices of the Royal Astronomical Society, 1995-11, Vol.277 (2), p.389-396

1995

Volltextzugriff (PDF)

8C1435+635: a radio galaxy at z = 4.25

Monthly notices of the Royal Astronomical Society, 1994-11, Vol.271 (2), p.504-512

1994

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Humans
(14)
Life Sciences & Biomedicine
(14)
Animals
(9)
Female
(9)
Biological And Medical Sciences
(8)
Immunology
(8)
Immunotherapy
(8)
Medical Sciences
(8)
Mice
(7)
Oncology
(6)
Receptors, Igg - Immunology
(6)
Adult
(5)
Antineoplastic Agents
(5)
Middle Aged
(5)
Pharmacology. Drug Treatments
(5)
Aged
(4)
Antibodies, Bispecific - Therapeutic Use
(4)
Hematology
(4)
Male
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial

Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc RI × anti-HER-2 neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations

IL-12: a promising adjuvant for cancer vaccination

FcγRI (CD64) Contributes Substantially to Severity of Arthritis, Hypersensitivity Responses, and Protection from Bacterial Infection

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcγRI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (Filgrastim) for treatment of advanced breast cancer

Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients

CpG oligodeoxynucleotides enhance FcγRI-mediated cross presentation by dendritic cells

Immunotherapeutic perspective for bispecific antibodies

Pegylated interferon-α2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy : The promise of monoclonal antibodies for the therapy of cancer

Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies

Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantation

CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

CpG oligodeoxynucleotides enhance Fc RI-mediated cross presentation by dendritic cells

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

Fc[gamma]RI (CD64) Contributes Substantially to Severity of Arthritis, Hypersensitivity Responses, and Protection from Bacterial Infection

Radio Continuum Imaging of High-redshift Radio Galaxies

Spatially resolved Lyα absorption in the z = 2.9 radio galaxy 0943–242

8C1435+635: a radio galaxy at z = 4.25

Suchergebnisse filtern